21
https://pubmed.ncbi.nlm.nih.gov/38113971
A Janus kinase (JAK)-Inhibitor may be a useful treatment for progesterone hypersensitivity (PH) when hormonal management alone is insufficient.
“JAK-Inhibitor: A Potential Treatment for Progesterone Hypersensitivity When Hormonal Management Is Insufficient”
